These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21112628)

  • 1. A scalable controlled-release device for transscleral drug delivery to the retina.
    Kawashima T; Nagai N; Kaji H; Kumasaka N; Onami H; Ishikawa Y; Osumi N; Nishizawa M; Abe T
    Biomaterials; 2011 Mar; 32(7):1950-6. PubMed ID: 21112628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transscleral sustained ranibizumab delivery using an episcleral implantable device: Suppression of laser-induced choroidal neovascularization in rats.
    Nagai N; Nezhad ZK; Daigaku R; Saijo S; Song Y; Terata K; Hoshi A; Nishizawa M; Nakazawa T; Kaji H; Abe T
    Int J Pharm; 2019 Aug; 567():118458. PubMed ID: 31247277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye.
    Nagai N; Kaji H; Onami H; Ishikawa Y; Nishizawa M; Osumi N; Nakazawa T; Abe T
    Acta Biomater; 2014 Feb; 10(2):680-7. PubMed ID: 24239899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transscleral Controlled Delivery of Geranylgeranylaceton Using a Polymeric Device Protects Rat Retina Against Light Injury.
    Nagai N; Kaji H; Nishizawa M; Nakazawa T; Abe T
    Adv Exp Med Biol; 2016; 854():471-7. PubMed ID: 26427448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of benzalkonium chloride on transscleral drug delivery.
    Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A drug refillable device for transscleral sustained drug delivery to the retina.
    Nagai N; Saijo S; Song Y; Kaji H; Abe T
    Eur J Pharm Biopharm; 2019 Mar; 136():184-191. PubMed ID: 30690065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transscleral sustained vasohibin-1 delivery by a novel device suppressed experimentally-induced choroidal neovascularization.
    Onami H; Nagai N; Kaji H; Nishizawa M; Sato Y; Osumi N; Nakazawa T; Abe T
    PLoS One; 2013; 8(3):e58580. PubMed ID: 23472209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
    Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T
    Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A self-deploying drug release device using polymeric films.
    Kondo T; Nezhad ZK; Suzuki J; Nagai N; Nishizawa M; Abe T; Kaji H
    J Biomed Mater Res B Appl Biomater; 2018 Feb; 106(2):780-786. PubMed ID: 28371212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delivery of macromolecular drugs to the vitreous and its peripheral tissues].
    Morita Y; Saino H; Tojo K
    Nihon Rinsho; 1998 Mar; 56(3):628-31. PubMed ID: 9549347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A platform for controlled dual-drug delivery to the retina: protective effects against light-induced retinal damage in rats.
    Nagai N; Kaji H; Onami H; Katsukura Y; Ishikawa Y; Nezhad ZK; Sampei K; Iwata S; Ito S; Nishizawa M; Nakazawa T; Osumi N; Mashima Y; Abe T
    Adv Healthc Mater; 2014 Oct; 3(10):1555-60, 1524. PubMed ID: 24753450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multilayered sheet-type device capable of sustained drug release and deployment control.
    Sato Y; Nagai N; Abe T; Kaji H
    Biomed Microdevices; 2019 Jul; 21(3):60. PubMed ID: 31257546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogel-based drug delivery systems: comparison of drug diffusivity and release kinetics.
    Brandl F; Kastner F; Gschwind RM; Blunk T; Tessmar J; Göpferich A
    J Control Release; 2010 Mar; 142(2):221-8. PubMed ID: 19887092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size-dependent dextran transport across rat alveolar epithelial cell monolayers.
    Matsukawa Y; Lee VH; Crandall ED; Kim KJ
    J Pharm Sci; 1997 Mar; 86(3):305-9. PubMed ID: 9050797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix-loaded biodegradable gelatin nanoparticles as new approach to improve drug loading and delivery.
    Ofokansi K; Winter G; Fricker G; Coester C
    Eur J Pharm Biopharm; 2010 Sep; 76(1):1-9. PubMed ID: 20420904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel technology using transscleral ultrasound to deliver protein loaded nanoparticles.
    Huang D; Wang L; Dong Y; Pan X; Li G; Wu C
    Eur J Pharm Biopharm; 2014 Sep; 88(1):104-15. PubMed ID: 24833007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery from episcleral exoplants.
    Pontes de Carvalho RA; Krausse ML; Murphree AL; Schmitt EE; Campochiaro PA; Maumenee IH
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4532-9. PubMed ID: 17003449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.
    Pitkänen L; Ranta VP; Moilanen H; Urtti A
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):641-6. PubMed ID: 15671294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.
    Parmentier J; Hartmann FJ; Fricker G
    Eur J Pharm Biopharm; 2010 Nov; 76(3):394-403. PubMed ID: 20849953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted cytosolic delivery of hydrogel nanoparticles into HepG2 cells through engineered Sendai viral envelopes.
    Jana SS; Bharali DJ; Mani P; Maitra A; Gupta CM; Sarkar DP
    FEBS Lett; 2002 Mar; 515(1-3):184-8. PubMed ID: 11943218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.